Pharma Nord UK is a leading developer and manufacturer of dietary supplements and natural medicines, with an emphasis on bioavailability, safety and documentation.
We supply pharmaceutical quality vitamins and dietary supplements. All of our products comply with extensive demands as to quality, safety and documentation, based on scientific insights harvested from more than 9,000 scientific research articles, including over 200 Pharma Nord product specific published trials. This is all part of a significant investment in research and development to ensure our products are the highest quality and compliant with regulatory requirements.
We together are involved in a very important industry. The forecast of sales of food supplements in the UK might reach £500 million by 2022.
To help our valued customers and to preserve the value of the Pharma Nord brand, we have decided to review our Selective Distribution System. A Selective Distribution System means that all our customers will sell only to end consumers, or to other partners who meet all the criteria below.
Please take the time to review the Selective Distribution Criteria, and if you agree to it, please complete the text fields below and click 'Submit'.
Any Partner found in breach of the Pharma Nord Selective Distribution Criteria will be suspended from the Network and notified in writing. The Partner must rectify this breach within 10 working days. Failure to rectify these issues will be considered as sufficient reason to permanently exclude the Partner from the Selective Distribution Network.
Please retain this document for future reference.